Nursing Pharmacology Practice Questions
Cancer Chemotherapy Chapters 33-34 Hydroxyurea
Click on the correct answer.
Choose the correct statement/statements concerning hydroxyurea:
- Classified as an antimetabolite
- Prevents conversion of ribonucleotides to deoxyribonucleotides.
- Both
- Neither
Hydroxyurea selectively inhibits ribonucleoside diphosphate reductase.
- True
- False
Hydroxyrurea:
- Stops the cell-cycle at the G1/S phase.
- Exibits radiation sensitizing activity
- Both
- Neither
Hydroxyurea is classified as an antileukemic drug.
- True
- False
In sickle cell anemia:
- Hydroxyrurea increases hemoglobin F levels
- Red blood cell water content
- Deformability of sickled cells
- Changes the character of red blood cell adhesion to the endothelium
- A & B
- B & C
- A & C
- A, B, C & D
- D
Concerning hydroxyurea pharmacokinetics/pharmacodynamics:
- Rapid and readily absorbed
- Widely distributed throughout the body; volume of distribution is about the same as total body water.
- Drug concentrates in erythrocytes and leukocytes
- Metabolism involves their metabolism and urease (intestinal bacteria)
- A & B
- B & D
- All responses (A, B, C & D) are correct
Hydroxyrurea administration results in substantial drug appearing in human breast milk.
- True
- False
In patients with renal dysfunction, changes in initial dosing appears indicated.
- True
- False
Clinical use/uses:
- Chronic myeloid leukemia (resistant)
- Head and neck cancer
- Sickle cell anemia
- All of the above
Primary use of hydroxyrurea: Myelosuppressive drug for management of myeloproliferative disease.
- True
- False
Clinical uses of hydroxyurea includes/includes:
- Chronic myelogenous leukemia (CML)
- Myeloid metaplasia
- Polycythemia
- Essential thrombocytosis
- A & B
- B & C
- A, B, C & D
Principal hydroxyrurea adverse effects/effects:
- Leukopenia
- Occasional thrombocytopenia
- Anemia
- All the above
Hydroxyurea exibits strata genicity in animal models and should not be used in women who may bear children.
- True
- False
If
you wish to return to the Table of Contents in ENGLISH, press
the RETURN button above. |
Otherwise, if the text is NOT displayed in English and
you are ready to leave this page,
Press here
to return to the Table of Contents
|